Daniyal Hussain

Executive Director, Technology Business Development - GSK

Daniyal is the Executive Director of the Technology Business Development organization at GSK. He focuses on novel platforms, data generation technologies and artificial intelligence in relation to drug discovery and development. Previously he was at Valo Health and has established data partnerships, in-licensed assets, acquired platforms and formed strategic partnerships. Prior to Valo he was in AstraZeneca's Immuno-Oncology strategy group.

Daniyal Hussain


  • Wednesday - May 29, 2024 - 10:00

    AI Partnerships with Pharma – What Pharma partners look for and key deal considerations


  • Wednesday - May 29, 2024 - 17:00

    Panel Discussion: Advancing Drug Discovery and Patient Care: The Synergy of Emerging Technologies in Pharma-Health Collaboration

    • Why is it important for pharma and healthcare to work together? •
    • The changing patient behaviour in the digital era
    • Why is it essential to be prompt in identifying and addressing the patient’s needs?
    • How will digitization help bring patients on board?
    • Progress made by companies so far
    • Strategies to be adopted to increase patient –company data flow


Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now